Skip to content

Semaglutide clinical trials: 210 trials

Page 2 of 5

  1. A Study Comparing the Dulaglutide Pen and the Semaglutide Pen

    NCT03724981 · Phase 4 · Completed

    Posted results

  2. A Trial Comparing the Safety and Efficacy of Semaglutide Once Weekly Versus Sitagliptin Once Daily in Japanese Subjects With Type 2 Diabetes

    NCT02254291 · Phase 3 · Completed

    Posted results

  3. Research Study Looking at How Well Semaglutide Tablets Taken Once Daily Work in People Who Have a Body Weight Above the Healthy Range

    NCT05564117 · Phase 3 · Completed

    Posted results

  4. Two-year Research Study Investigating How Well Semaglutide Works in People Suffering From Overweight or Obesity

    NCT03693430 · Phase 3 · Completed

    Posted results

  5. Efficacy and Safety of Semaglutide Once-weekly Versus Placebo as add-on to SGLT-2i in Subjects With Type 2 Diabetes Mellitus

    NCT03086330 · Phase 3 · Completed

    Posted results

  6. Dose-response, Safety and Efficacy of Oral Semaglutide Versus Placebo and Versus Liraglutide, All as Monotherapy in Japanese Subjects With Type 2 Diabetes

    NCT03018028 · Phase 3 · Completed

    Posted results

  7. A Research Study to See How Well Semaglutide Helps People Who Have a Body Weight Above the Healthy Weight Range

    NCT06041217 · Phase 3 · Completed

    Posted results

  8. Research Study Looking at How Well Semaglutide Works in People Living With Obesity and Prediabetes

    NCT05040971 · Phase 3 · Completed

    Posted results

  9. Research Study to Investigate How Well Semaglutide Tablets Taken Once Daily Work in East Asian People Who Are Overweight or Living With Obesity

    NCT05132088 · Phase 3 · Completed

    Posted results

  10. A Research Study on How Well Semaglutide Works in Adolescents With Overweight or Obesity

    NCT04102189 · Phase 3 · Completed

    Posted results

  11. Research Study Investigating How Well Semaglutide Works in People From Thailand and South Korea Living With Obesity

    NCT04998136 · Phase 3 · Completed

    Posted results

  12. A Research Study to See How a New Weekly Insulin, Insulin Icodec When Given Along With Semaglutide Helps in Reducing the Blood Sugar Level in Patients With Type 2 Diabetes

    NCT05813912 · Phase 3 · Completed

    Posted results

  13. A Research Study to Compare a New Medicine Oral Semaglutide to a Dummy Medicine in Children and Teenagers With Type 2 Diabetes

    NCT04596631 · Phase 3 · Completed

    Posted results

  14. Semaglutide Treatment, Appetite, and Eating Behavior: Long-term Effects

    NCT05548647 · Phase 4 · Completed

    Posted results

  15. A Research Study to Find Out How Semaglutide Works in the Kidneys Compared to Placebo, in People With Type 2 Diabetes and Chronic Kidney Disease (the REMODEL Trial)

    NCT04865770 · Phase 3 · Completed

    Posted results

  16. Safety Study of Weekly Semaglutide in Chilean Participants With Type 2 Diabetes

    NCT05533632 · Phase 4 · Completed

    Posted results

  17. Comparison of Injection Site Pain Experience for Semaglutide and Dulaglutide sc

    NCT04189848 · Phase 4 · Completed

    Posted results

  18. Holding vs. Continuing Incretin-based Therapies Before Upper Endoscopy

    NCT06533527 · Phase 4 · Completed

    Posted results

  19. Treating PCOS With Semaglutide vs Active Lifestyle Intervention

    NCT03919929 · Phase 2/3 · Completed

    Posted results

  20. Transition From Basal/Bolus to Once-weekly Subcutaneous Semaglutide and Basal Insulin in Patients With T2D

    NCT04538352 · Phase 4 · Completed

    Posted results

  21. A Research Study Looking at the Effect of Semaglutide on the Immune System and Other Biological Processes in People With Alzheimer's Disease

    NCT05891496 · Phase 3 · Completed

    Posted results

  22. Effect of GLP1 Receptor Agonists on Physical Function, Body Composition, and Markers of Aging in Older Adults

    NCT05786521 · Phase 4 · Completed

    Posted results

  23. Effect of Subcutaneous Semaglutide on Kidney Transplant Candidacy

    NCT04741074 · Phase 3 · Terminated

    Posted results

  24. Impact of Semaglutide on CD34+ EPC and Fat Derived MSC

    NCT04126603 · Phase 4 · Completed

    Posted results

  25. Semaglutide in CFRD

    NCT05788965 · Phase 2/3 · Completed

    Posted results

  26. Treatment of GLP-1 for Diabetic Bariatric Patients

    NCT04624672 · Phase 4 · Terminated

    Posted results

  27. A Research Study to See How Well CagriSema Helps People With Excess Body Weight Lose Weight

    NCT05567796 · Phase 3 · Active, not recruiting

    Linked paper with results

  28. A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE)

    NCT04777396 · Phase 3 · Completed

    Linked paper with results

  29. A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE Plus)

    NCT04777409 · Phase 3 · Completed

    Linked paper with results

  30. Research Study on Whether Semaglutide Works in People With Non-alcoholic Steatohepatitis (NASH)

    NCT04822181 · Phase 3 · Active, not recruiting

    Linked paper with results

  31. A Research Study to See How Well CagriSema Helps People With Type 2 Diabetes and Excess Body Weight Lose Weight

    NCT05394519 · Phase 3 · Completed

    Linked paper with results

  32. Semaglutide in Patients Undergoing Transcatether Aortic Valve Replacement

    NCT07090343 · Phase 3 · Not yet recruiting

    Linked paper with results

  33. Research Study to Look at How Well Semaglutide Works in People Living With Heart Failure, Obesity and Type 2 Diabetes

    NCT04916470 · Phase 3 · Completed

    Linked paper with results

  34. Efficacy of Semaglutide in Improving Neurological Outcomes After Endovascular Thrombectomy for Acute Ischemic Stroke: A Randomized Double-Blind Controlled Trial

    NCT07030621 · Phase 3 · Not yet recruiting

    Linked paper with results

  35. GLP-1 Agonists for Prevention of Recurrent Hypertriglyceridemic Acute Pancreatitis

    NCT07617155 · Phase 4 · Not yet recruiting

    Linked paper with results

  36. A Research Study to See How Well CagriSema Helps People in East Asia With Excess Body Weight Lose Weight

    NCT05813925 · Phase 3 · Completed

    Linked paper with results

  37. A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in People With Type 2 Diabetes Treated With Once-daily Basal Insulin With or Without Metformin

    NCT06323161 · Phase 3 · Completed

    Linked paper with results

  38. Young Adults With Early-onset Obesity Treated With Semaglutide

    NCT05574439 · Phase 4 · Completed

    Linked paper with results

  39. A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in People With Type 2 Diabetes Treated With Diet and Exercise

    NCT06323174 · Phase 3 · Completed

    Linked paper with results

  40. Semaglutide 2.4mg for Low Responders After Bariatric Surgery

    NCT06287307 · Phase 4 · Status unknown

    Linked paper with results

  41. SeMaglutide and Albuminuria Reduction Trial in Obese Individuals Without Diabetes

    NCT04889183 · Phase 3 · Completed

    Linked paper with results

  42. Efficacy of Oral Semaglutide in Overweight or Obesity

    NCT05442450 · Phase 4 · Status unknown

    Linked paper with results

  43. Does GLP-1RA Prevent Deterioration of Metabolic State in Prediabetic and Diabetic Patients Treated With Antipsychotic Medication?

    NCT04892199 · Phase 4 · Status unknown

    Linked paper with results

  44. Semaglutide and Vascular Regeneration

    NCT05870462 · Phase 4 · Status unknown

    Linked paper with results

  45. SHAPE-ENDO: Pilot Randomized Trial of Multimodal Pre-Surgical Optimization Versus Standard Surgery in Patients With Obesity and Early-Stage Endometrial Cancer

    NCT07462663 · Phase 4 · Not yet recruiting

    Linked paper with results

  46. Comparison of Body Weight Change Through Different Smeglutide Administration Methods

    NCT05616052 · Phase 4 · Status unknown

    Linked paper with results

  47. Renal Effects of Treatment With Empagliflozin Alone or in Combination With Semaglutide in Patients With Type 2 Diabetes and Albuminuria

    NCT04061200 · Phase 4 · Status unknown

    Linked paper with results

  48. Semaglutide Improves Metabolic Abnormalities and Fertility in Obese Infertile Women With Polycystic Ovary Syndrome

    NCT05702905 · Phase 4 · Status unknown

    Linked paper with results

  49. Semaglutide 2.4 mg in Patients With Poor Weight-loss

    NCT05073835 · Phase 3 · Active, not recruiting

    Linked paper with results

  50. Rapid and Simultaneous Initiation of Four Guideline-Directed CKD Therapies (RAPID-CKD)

    NCT07547878 · Phase 4 · Enrolling by invitation

    Linked paper with results

How PepBank reports evidence